{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:04:47Z","timestamp":1773176687974,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf02251133","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T17:10:34Z","timestamp":1132074634000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl"],"prefix":"10.1007","volume":"3","author":[{"given":"E.","family":"Martignoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Blandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sinforiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1991,3,1]]},"reference":[{"key":"BF02251133_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135: 216\u2013223","journal-title":"Br J Psychiatry"},{"key":"BF02251133_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/0024-3205(80)90025-9","volume":"27","author":"R Adolfsson","year":"1980","unstructured":"Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029\u20131034","journal-title":"Life Sci"},{"issue":"2","key":"BF02251133_CR3","first-page":"109","volume":"1","author":"A Agnoli","year":"1990","unstructured":"Agnoli A, Martucci N, Fabbrini G, Buckley AE, Fioravanti M (1990) Monoamine oxidase and dementia: treatment with an inhibitor of MAO-B activity. Dementia 1(2): 109\u2013114","journal-title":"Dementia"},{"key":"BF02251133_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1176\/ajp.141.1.97","volume":"141","author":"R Alexopoulus","year":"1984","unstructured":"Alexopoulus R, Lieberman KW, Young RC (1984) Platelet MAO activity in primary degenerative dementia of the Alzheimer type. Am J Psychiatry 141: 97\u201399","journal-title":"Am J Psychiatry"},{"key":"BF02251133_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3565(25)26438-2","volume":"138","author":"AH Anton","year":"1962","unstructured":"Anton AH, Sayre DF (1962) A study of the factor affecting the aluminum oxide-trihydroxyindole procedure for the analysis of the catecholamines. J Pharmacol Exp Ther 138: 360\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02251133_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","volume":"43","author":"H Arai","year":"1984","unstructured":"Arai H, Kosaka K, Iizuka R (1984) Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem 43: 388\u2013393","journal-title":"J Neurochem"},{"key":"BF02251133_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0010-9452(64)80020-4","volume":"1","author":"C Arrigoni","year":"1964","unstructured":"Arrigoni C, De Renzi E (1964) Constructional apraxia and hemispheric locus of lesion. Cortex 1: 170\u2013197","journal-title":"Cortex"},{"key":"BF02251133_CR8","volume-title":"Contributions to neuropsychological assessment","author":"AL Benton","year":"1983","unstructured":"Benton AL, Hamsher K de S, Varney NR, Spreen O (1983) Contributions to neuropsychological assessment. Oxford University Press, New York"},{"key":"BF02251133_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0140-6736(77)91940-7","volume":"i","author":"W Birkmayer","year":"1977","unstructured":"Birkmayer W, Riederer P, Ambrozi L (1977) Implications of combined treatment with \u201cMadopar\u201d and 1-Deprenyl in Parkinson's disease. A long term study. Lancet i: 439\u2013443","journal-title":"Lancet"},{"key":"BF02251133_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00002826-198205020-00004","volume":"5","author":"W Birkmayer","year":"1982","unstructured":"Birkmayer W, Riederer P, Youdim MBH (1982) (\u2212) Deprenyl in the treatment of Parkinson's disease. Clin Neuropharmacol 5: 195\u2013230","journal-title":"Clin Neuropharmacol"},{"key":"BF02251133_CR11","first-page":"1247","volume":"i","author":"W Bondareff","year":"1981","unstructured":"Bondareff W, Mountjoy CQ, Roth M (1981) Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus caeruleus) in senile dementia. Lancet i: 1247\u20131249","journal-title":"Lancet"},{"key":"BF02251133_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0022-510X(83)90149-1","volume":"60","author":"AJ Cross","year":"1983","unstructured":"Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE (1983) Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci 60: 382\u2013392","journal-title":"J Neurol Sci"},{"key":"BF02251133_CR13","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"ii","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii: 1403","journal-title":"Lancet"},{"key":"BF02251133_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-8993(79)90336-6","volume":"171","author":"P Davies","year":"1979","unstructured":"Davies P (1979) Neurotransmitter-related enzymes in senile dementia of Alzheimer type. Brain Res 171: 319\u2013327","journal-title":"Brain Res"},{"key":"BF02251133_CR15","unstructured":"De Renzi E (1977) Le amnesie. Neuropsicologia Clinica. Angeli F (ed) Milano, pp 199\u2013246"},{"key":"BF02251133_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF00426954","volume":"57","author":"D Elsworth","year":"1978","unstructured":"Elsworth D, Glover V, Reynolds GP, Sandler M, Less AJ, Phuapradit P, Shaw KM, Stein GM, Kumar P (1978) Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the \u201ccheese effect\u201d. Psychopharmacology 57: 33\u201338","journal-title":"Psychopharmacology"},{"key":"BF02251133_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189\u2013198","journal-title":"J Psychiatr Res"},{"key":"BF02251133_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01249185","volume":"49","author":"CJ Fowler","year":"1980","unstructured":"Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49: 1\u201320","journal-title":"J Neural Transm"},{"key":"BF02251133_CR19","first-page":"501","volume":"7","author":"CJ Fowler","year":"1982","unstructured":"Fowler CJ (1982) Selective inhibitors of MAO types A and B and their clinical usefulness. Drugs Future 7: 501\u2013517","journal-title":"Drugs Future"},{"key":"BF02251133_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM198507043130102","volume":"313","author":"PT Francis","year":"1985","unstructured":"Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. N Engl J Med 313: 7\u201311","journal-title":"N Engl J Med"},{"key":"BF02251133_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0010-9452(77)80002-6","volume":"13","author":"G Gainotti","year":"1977","unstructured":"Gainotti G, Miceli G, Caltagirone C (1977) Constructional apraxia in left brain-damaged patients: a planning disorder? Cortex 13: 109\u2013118","journal-title":"Cortex"},{"key":"BF02251133_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF00433804","volume":"72","author":"N Garrick","year":"1980","unstructured":"Garrick N, Murphy DL (1980) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 72: 27\u201333","journal-title":"Psychopharmacology"},{"key":"BF02251133_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1192\/bjp.115.522.563","volume":"115","author":"CG Gottfries","year":"1969","unstructured":"Gottfries CG, Gottfries I, Roos BE (1969) The investigation of homovanillic acid in the human brain and its correlation to senile dementia. Br J Psychiatry 115: 563\u2013574","journal-title":"Br J Psychiatry"},{"key":"BF02251133_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1471-4159.1969.tb05984.x","volume":"16","author":"CG Gottfries","year":"1969","unstructured":"Gottfries CG, Gottfries I, Roos BE (1969) Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. J Neurochem 16: 1341\u20131345","journal-title":"J Neurochem"},{"key":"BF02251133_CR25","first-page":"99","volume":"46","author":"CG Gottfries","year":"1970","unstructured":"Gottfries CG, Gottfries I, Roos BE (1970) Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia. Acta Psychiatr Scand 46: 99\u2013105","journal-title":"Acta Psychiatr Scand"},{"key":"BF02251133_CR26","first-page":"429","volume":"6","author":"CG Gottfries","year":"1976","unstructured":"Gottfries CG, Roos BE, Winblad B (1976) Monoamine and monoamine metabolites in the human brain post mortem in senile dementia. Acta Gerontol 6: 429\u2013435","journal-title":"Acta Gerontol"},{"key":"BF02251133_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000212588","volume":"28","author":"CG Gottfries","year":"1982","unstructured":"Gottfries CG, Brane G, Steen G (1982) A new clinical rating scale for dementia syndromes. Gerontology 28: 20\u201331","journal-title":"Gerontology"},{"key":"BF02251133_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0197-4580(83)90002-7","volume":"4","author":"CG Gottfries","year":"1983","unstructured":"Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernas SA, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type (AD\/SDAT). Neurobiol Aging 4: 262\u2013271","journal-title":"Neurobiol Aging"},{"key":"BF02251133_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Iliff LE, Zilkha E, Duboulay GH, McAllister VA, Marshall J, Russel RWR, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632\u2013637","journal-title":"Arch Neurol"},{"key":"BF02251133_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"MA Hamilton","year":"1960","unstructured":"Hamilton MA (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02251133_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-510X(89)90179-2","volume":"92","author":"P Herregodts","year":"1989","unstructured":"Herregodts P, Bruyland M, De Keyser J, Solheid C, Michotte Y, Ebinger G (1989) Monoaminergic neurotransmitters in Alzheimer's disease. J Neurol Sci 92: 101\u2013116","journal-title":"J Neurol Sci"},{"key":"BF02251133_CR32","first-page":"135","volume":"39","author":"J Knoll","year":"1976","unstructured":"Knoll J (1976) Analysis of the pharmacological effects of selective monoamine oxidase inhibitors. CIBA Found Symp 39: 135\u2013161","journal-title":"CIBA Found Symp"},{"key":"BF02251133_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(77)90725-5","volume":"ii","author":"AJ Lees","year":"1977","unstructured":"Lees AJ, Shaw KM, Kohout LJ, Stern GM, Elsworth JD, Sandler M, Youdim MBH (1977) Deprenyl in Parkinson's disease. Lancet ii: 791\u2013795","journal-title":"Lancet"},{"key":"BF02251133_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00004714-198202000-00008","volume":"2","author":"JJ Mann","year":"1982","unstructured":"Mann JJ, Frances A, Kaplan RD, Kocsis J, Peselow ED, Gershon S (1982) The relative efficacy of L-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression. J Clin Psychopharmacol 2: 54\u201357","journal-title":"J Clin Psychopharmacol"},{"key":"BF02251133_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G Mc Khann","year":"1984","unstructured":"Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939\u2013944","journal-title":"Neurology"},{"issue":"2","key":"BF02251133_CR36","first-page":"182","volume":"1","author":"GV Melzi d'Eril","year":"1986","unstructured":"Melzi d'Eril GV (1986) A rapid and simple method for determining catecholamines in human plasma and cerebrospinal fluid using high-performance liquid chromatography with electrochemical detection. Funct Neurol 1 (2): 182\u2013190","journal-title":"Funct Neurol"},{"key":"BF02251133_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1192\/bjp.142.5.508","volume":"142","author":"J Mendlewicz","year":"1983","unstructured":"Mendlewicz J, Youdim MBH (1983) L-deprenyl, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. Br J Psychiatry 142: 508\u2013511","journal-title":"Br J Psychiatry"},{"key":"BF02251133_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00431109","volume":"73","author":"N Mendis","year":"1981","unstructured":"Mendis N, Pare CMB, Sandler M, Glover V, Stern GM (1981) Is the failure of (\u2212) deprenyl, a selective monoamine oxidase type B inhibitor, to alleviate depression related to freedom from the cheese effect? Psycopharmacology 73: 87\u201390","journal-title":"Psycopharmacology"},{"key":"BF02251133_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jnnp.47.5.481","volume":"47","author":"AM Palmer","year":"1984","unstructured":"Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 47: 481\u2013484","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02251133_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00002826-199004000-00004","volume":"2","author":"GL Piccinin","year":"1990","unstructured":"Piccinin GL, Finali G, Piccirilli M (1990) Neuropsychological effects of L-deprenyl in Alzheimer's type dementia. Clin Neuropharmacol 2: 147\u2013163","journal-title":"Clin Neuropharmacol"},{"key":"BF02251133_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archpsyc.1984.01790150033006","volume":"41","author":"MA Raskind","year":"1984","unstructured":"Raskind MA, Peskind ER, Halter JB, Jimerson DC (1984) Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry 41: 343\u2013346","journal-title":"Arch Gen Psychiatry"},{"key":"BF02251133_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","volume":"9","author":"KJ Reinikainen","year":"1988","unstructured":"Reinikainen KJ, Palj\u00e4rvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9: 245\u2013252","journal-title":"Neurobiol Aging"},{"key":"BF02251133_CR43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, De Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136\u20131139","journal-title":"Am J Psychiatry"},{"key":"BF02251133_CR44","volume-title":"L'examen clinique en psychologie","author":"A Rey","year":"1964","unstructured":"Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris"},{"key":"BF02251133_CR45","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/0024-3205(80)90176-9","volume":"26","author":"JA Richter","year":"1980","unstructured":"Richter JA, Perry EK, Tomlinson BE (1980) Acetylcholine and choline levels in postmortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci 26: 1683\u20131689","journal-title":"Life Sci"},{"key":"BF02251133_CR46","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/clinchem\/33.6.844","volume":"33","author":"V Rizzo","year":"1987","unstructured":"Rizzo V, Melzi d'Eril GV (1987) Determination of free 3-methoxy-hydroxy-phenylethyleneglycol in plasma and cerebrospinal fluid by liquid chromatography with coulometric detection. Clin Chem 33: 844\u2013845","journal-title":"Clin Chem"},{"key":"BF02251133_CR47","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archpsyc.1971.01750120052009","volume":"24","author":"DS Robinson","year":"1971","unstructured":"Robinson DS, Davis JM, Nies A, Ravaris CL, Sylwester D (1971) Relation of sex and aging to monoamine oxidase activity in human brain, plasma and platelets. Arch Gen Psychiatry 24: 536\u2013539","journal-title":"Arch Gen Psychiatry"},{"key":"BF02251133_CR48","first-page":"81","volume":"77","author":"H Simon","year":"1981","unstructured":"Simon H (1981) Neurones dopaminergiques A 10 et systeme frontal. J Physiol (Paris) 77: 81\u201395","journal-title":"J Physiol (Paris)"},{"key":"BF02251133_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-0404.1981.tb04392.x","volume":"64","author":"H Soininen","year":"1981","unstructured":"Soininen H, Mac Donald E, Rekonen M, Riekkinen PJ (1981) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 101\u2013107","journal-title":"Acta Neurol Scand"},{"key":"BF02251133_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/02643298808252933","volume":"5","author":"H Spinnler","year":"1988","unstructured":"Spinnler H, Della Sala S, Bandera R, Baddeley A (1988) Dementia, aging and the structure of human memory. Cogn Neuropsychol 5: 193\u2013211","journal-title":"Cogn Neuropsychol"},{"key":"BF02251133_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00518180","volume":"91","author":"T Sunderland","year":"1987","unstructured":"Sunderland T, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL (1987) Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease. Psychopharmacology 91: 293\u2013296","journal-title":"Psychopharmacology"},{"key":"BF02251133_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF00216016","volume":"91","author":"PN Tariot","year":"1987","unstructured":"Tariot PN, Sunderland T, Weingartner H, Murphy DL, Welkowitz JA, Thompson K, Cohen RM (1987a) Cognitive effects of L-deprenyl in Alzheimer's disease. Psychopharmacology 91: 489\u2013495","journal-title":"Psychopharmacology"},{"key":"BF02251133_CR53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archpsyc.1987.01800170041007","volume":"44","author":"PN Tariot","year":"1987","unstructured":"Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow A, Weingartner H, Mueller EA, Murphy DL (1987b) L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch Gen Psychiatry 44: 427\u2013433","journal-title":"Arch Gen Psychiatry"},{"key":"BF02251133_CR54","volume-title":"The measurement and appraisal of adult intelligence","author":"D Wechsler","year":"1958","unstructured":"Wechsler D (1958) The measurement and appraisal of adult intelligence, 4th ed. Williams and Wilkins, Baltimore","edition":"4th ed."},{"key":"BF02251133_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","volume":"10","author":"PJ Whitehouse","year":"1981","unstructured":"Whitehouse PJ, Price DL, Clark AW, Coyle JT, Delong MK (1981) Alzheimer disease: evidence of selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10: 122\u2013126","journal-title":"Ann Neurol"},{"key":"BF02251133_CR56","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0024-3205(82)90099-6","volume":"31","author":"PL Wood","year":"1982","unstructured":"Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NPV (1982) Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci 31: 2073\u20132079","journal-title":"Life Sci"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02251133\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:03:08Z","timestamp":1750824188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02251133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF02251133"],"URL":"https:\/\/doi.org\/10.1007\/bf02251133","relation":{},"ISSN":["0936-3076"],"issn-type":[{"value":"0936-3076","type":"print"}],"subject":[],"published":{"date-parts":[[1991,3]]},"assertion":[{"value":"17 October 1990","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 1991","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 1991","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}